DYSPNOEA is the #11 most commonly reported adverse reaction for NICOTINE, manufactured by Haleon US Holdings LLC. There are 1,110 FDA adverse event reports linking NICOTINE to DYSPNOEA. This represents approximately 1.5% of all 74,737 adverse event reports for this drug.
NICOTINE has an overall safety score of 78 out of 100. Patients taking NICOTINE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DYSPNOEA1,110 of 74,737 reports
DYSPNOEA is a less commonly reported adverse event for NICOTINE, but still significant enough to appear in the safety profile.
Other Side Effects of NICOTINE
In addition to dyspnoea, the following adverse reactions have been reported for NICOTINE:
DYSPNOEA has been reported as an adverse event in 1,110 FDA reports for NICOTINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DYSPNOEA with NICOTINE?
DYSPNOEA accounts for approximately 1.5% of all adverse event reports for NICOTINE, making it a notable side effect.
What should I do if I experience DYSPNOEA while taking NICOTINE?
If you experience dyspnoea while taking NICOTINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.